68 results on '"Angulo, Paul"'
Search Results
2. Strengthening the bones in primary biliary cirrhosis
3. Evaluating Risks and Complications of Liver Biopsy in Children Receiving Biopsy for Diagnosis and Treatment
4. Acute Esophageal Necrosis
5. The Evaluation of Hepatic Fibrosis Scores in Children with Nonalcoholic Fatty Liver Disease
6. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study
7. Varices in Early Histological Stage Primary Biliary Cirrhosis
8. Diagnosing steatohepatitis and predicting liver‐related mortality in patients with NAFLD: Two distinct concepts
9. Relations of Steatosis Type, Grade, and Zonality to Histological Features in Pediatric Nonalcoholic Fatty Liver Disease
10. Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
11. Corrections: Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?
12. Correction: Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial
13. Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?
14. The Relationship of Steatosis Grade, Zone and Type to Key Histological Features in Children with Nonalcoholic Fatty Liver Disease
15. Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial
16. Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study
17. Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
18. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
19. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease
20. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis
21. Light to Moderate Alcohol Consumption Is Associated With Lower Frequency of Hypertransaminasemia
22. Cholangiocarcinoma in Young Individuals With and Without Primary Sclerosing Cholangitis
23. Overlap of Autoimmune Hepatitis and Primary Biliary Cirrhosis: Long-Term Outcomes
24. Abnormal Hepatic Biochemistries in Patients With Inflammatory Bowel Disease
25. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
26. NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice
27. Nonalcoholic fatty liver disease and liver transplantation
28. Mycophenolate Mofetil for the Treatment of Primary Biliary Cirrhosis in Patients with an Incomplete Response to Ursodeoxycholic Acid
29. Secondary Sclerosing Cholangitis: A Comparison to Primary Sclerosing Cholangitis
30. Insulin Resistance, Auto-antibodies, and Nonalcoholic Fatty Liver Disease Response to Letter
31. Mycophenolate Mofetil for the Treatment of Primary Sclerosing Cholangitis
32. Alendronate improves bone mineral density in primary biliary cirrhosis: A randomized placebo-controlled trial
33. A Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis
34. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
35. Open-Label Pilot Study of Tetracycline in the Treatment of Primary Biliary Cirrhosis
36. Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
37. Ursodeoxycholic Acid and Long-Term Survival in Primary Biliary Cirrhosis
38. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
39. Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis
40. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis
41. Medical treatment for primary sclerosing cholangitis: Risk versus benefit
42. Association of Primary Biliary Cirrhosis and Rheumatoid Arthritis
43. Recurrent Idiopathic Hepatitis: A New Entity?
44. Treatment With Ursodeoxycholic Acid Is Associated With Weight Gain in Patients With Primary Biliary Cirrhosis
45. Is There A Role for Liver Biopsy in Primary Sclerosing Cholangitis?
46. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis
47. Results of long-term ursodiol treatment for patients with primary biliary cirrhosis
48. Small-duct primary sclerosing cholangitis: A long-term follow-up study
49. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system
50. Response to Dr. Sekhon
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.